EVOLUTIONOFMS.COM

Since the 1960s, astounding progress has been made in understanding and treating MS. Check out the decades below to learn more about key developments and see how far we've come... Celgene announced results from the phase III RADIANCE Part B trial evaluating the efficacy and safety of a novel, oral investigational agent in patients with relapsing multiple sclerosis at #ECTRIMS #MSParis2017 Click to read more